ASLAN Pharmaceuticals Ltd ADR (NASDAQ:ASLN) traded at $0.71 at close of the session on Tuesday, March 19, made a downward move of -11.21% on its previous day’s price.
Looking at the stock we see that its previous close was $0.80 and the beta (5Y monthly) reads 1.49 . In terms of its 52-week price range, ASLN has a high of $4.69 and a low of $0.39. The company’s stock has gained about 36.52% over that past 30 days.
ASLAN Pharmaceuticals Ltd ADR has a market cap of $11.83 million and is expected to release its quarterly earnings report on Mar 25, 2024 – Mar 31, 2024. Estimates by analysts give the company expected earnings per share (EPS) of -$0.65, with the EPS growth for the year raised at -$2.61 for 2023 and -$3.48 for next year. These figures represent 29.10% and -33.30% growth in EPS for the two years respectively.
There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the ASLN stock, short term indicators assign the stock an average of Hold, while medium term indicators assign it an average of 50% Sell. Long term indicators on average place the stock in the category of 50% Sell.
Looking further, we note the current price level is 6.75% off its SMA20 and 13.34% from its 50-day simple moving average. The RSI (14) is pointing at 50.67 while the volatility over the past week is 27.83% and jumps to 39.13% over the past one month. The beta value is 1.48, while the average true range (ATR) is currently pointing at 0.24.
Coming back to ASLAN Pharmaceuticals Ltd ADR (NASDAQ:ASLN), we note that the average 3-month trading volume was 999.35K, while that of the preceding 10-day period stands at 4.9 million. Current shares outstanding are 16.67 million.
The insiders hold 3.48% of the company’s shares while institutions hold 20.89%. The data shows that short shares as of Feb 29, 2024, stood at 19330.0 at a short ratio of 0.09. This represents a 0.12% short interest in shares outstanding on Feb 29, 2024. Shares short fall in February from the previous month at 58670.0. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 35.97% up in year-to-date price movement.
